Surgery Partners Inc (SGRY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Surgery Partners Inc (SGRY) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($83.60 Million) by net assets ($3.55 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SGRY company net worth for the company's overall valuation and market capitalisation.
Surgery Partners Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Surgery Partners Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Surgery Partners Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Surgery Partners Inc ranked by their cash flow conversion efficiency. Explore Surgery Partners Inc earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hyundai Doosan Infracore Co Ltd
KO:042670
|
0.072x |
|
Globant SA
NYSE:GLOB
|
0.041x |
|
Watsco Inc
NYSE:WSO-B
|
-0.006x |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
-0.009x |
|
Cimpress plc
F:3UF
|
-0.277x |
|
Melco Resorts & Entertainment Ltd
NASDAQ:MLCO
|
-0.046x |
|
IQM Quantum Computers Oyj American Depositary Shares
NASDAQ:IQMX
|
-0.120x |
|
Emami Limited
NSE:EMAMILTD
|
0.081x |
Annual Cash Flow Conversion Efficiency for Surgery Partners Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Surgery Partners Inc from 2013 to 2024. View current stock price of Surgery Partners Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.64 Billion | $300.10 Million | 0.083x | -5.54% |
| 2023-12-31 | $3.36 Billion | $293.80 Million | 0.087x | +80.67% |
| 2022-12-31 | $3.28 Billion | $158.80 Million | 0.048x | +27.72% |
| 2021-12-31 | $2.30 Billion | $87.10 Million | 0.038x | -75.10% |
| 2020-12-31 | $1.62 Billion | $246.90 Million | 0.152x | +99.58% |
| 2019-12-31 | $1.70 Billion | $129.50 Million | 0.076x | -- |
| 2018-12-31 | $0.00 | $144.60 Million | x | -- |
| 2017-12-31 | $0.00 | $120.94 Million | x | -- |
| 2016-12-31 | $0.00 | $125.24 Million | x | -- |
| 2015-12-31 | $0.00 | $84.48 Million | x | -- |
| 2014-12-31 | $222.12 Million | $21.95 Million | 0.099x | +102.89% |
| 2013-12-31 | $-14.38 Million | $49.08 Million | -3.414x | -- |
About Surgery Partners Inc
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers … Read more